Changes in <i>qnr</i> Prevalence and Fluoroquinolone Resistance in Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Enterobacter</i> spp. Collected from 1990 to 2005

Jacob Strahilevitz(Hebrew University of Jerusalem), Ari Robicsek(NorthShore University HealthSystem), Amos Adler(Istituto Superiore di Sanità), Dalia Engelstein(Hebrew University of Jerusalem), Colin Block, Allon E. Moses(Hadassah Medical Center), Violeta Temper(Hebrew University of Jerusalem)
Antimicrobial Agents and Chemotherapy
May 26, 2007
10.1128/aac.00256-07
Cited by 47

Related Papers

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
A whole-slide foundation model for digital pathology from real-world data
|Nature|2024|761
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749